Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: Value of positron emission tomography in diagnosis

Mayo Clinic Proceedings

Volumn 83, Issue 8, 2008, Pages 917-922

  Patel, Rajesh R ^a   Subramaniam, Rathan M ^a   Mandrekar, Jaywant N ^a   Hammack, Julie E ^a   Lowe, Val J ^a   Jett, James R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; THYMOMA; UTERINE TUBE CARCINOMA;

EID: 49249137501     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.8.917     Document Type: Article

References (18)

1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543-1554.
2. Darnell RB. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A. 1996;93(10):4529-4536.
3. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56(5):715-719.
4. Bredholt G, Storstein A, Haugen M, et al. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. Scand J Immunol. 2006;64(3):325-335.
5. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology. 1988;38(9):1391-1398.
6. Moll JW, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands. Neurology. 1995;45(10):1937-1941.
7. Darnell RB. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol. 2004;61(1):30-32.
8. Albert ML, Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer. 2004;4(1):36-44.
9. Nardelli E, Curro-Dossi B, Rizzuto N, Graus F. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites. Clin Neurol Neurosurg. 1995;97(1):89-94.
10. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology. 2002;59(5):764-766.
11. Rojas-Marcos I, Rousseau A, Keime-Guibert F, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine (Baltimore). 2003;82(3):216-223.
12. Voltz R, Graus F. Diagnosis and treatment of paraneoplastic neurological disorders. Onkologie. 2004;27(3):253-258.
13. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(pt 6):1138-1148.
14. Vedeler CA, Antoine JC, Giometto B, et al, Paraneoplastic Neurological Syndrome Euronetwork. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13(7):682-690.
15. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135-1140.
16. Bataller L, Graus F, Saiz A, Vilchez JJ, Spanish Opsoclonus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124(pt 2):437-443.
17. Graus F, Bonaventura I, Uchuya M, et al. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology. 1994;44(12):2258-2261.
18. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet. 1993;341(8836):21-22.